Skip to content

WALPHARMA: what changed

BE 0442.452.731NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2023 and 2024

Net result for the year
-€27,936
2023 · -€26,815-€1,121
Equity
€98,407
2023 · €126,343-€27,936
Cash
€49,208
2023 · €53,691-€4,483
Balance sheet total
€202,753
2023 · €276,687-€73,934

Largest movements

2023 to 2024
Assets
  • Receivables within one year -€37,141

    down €37,141 (-66.4%), from €55,957 to €18,815

    of which Other amounts receivable: -€33,967

  • Tangible fixed assets -€20,663

    down €20,663 (-82.8%), from €24,951 to €4,287

    of which Other tangible fixed assets: -€17,069

  • Current investments -€15,000

    down €15,000 (-24.8%), from €60,453 to €45,453

  • Stocks and contracts +€5,383

    up €5,383 (+7.5%), from €71,403 to €76,785

  • Cash -€4,483

    down €4,483 (-8.3%), from €53,691 to €49,208

    mainly Net result for the year (-€27,936) and Tax, wage and social debts (-€21,288)

Equity and liabilities
  • Profit (loss) carried forward -€27,936

    down €27,936 (-26.4%), from €105,892 to €77,956

  • Tax, wage and social debts -€21,288

    down €21,288 (-83.1%), from €25,614 to €4,326

    of which Taxes: -€14,966

  • Trade debts -€14,626

    down €14,626 (-39.2%), from €37,282 to €22,656

  • Debts after one year -€11,268

    no longer reported in 2024; in 2023 it stood at €11,268

  • Other debts +€3,342

    up €3,342 (+5.3%), from €62,797 to €66,139

Income statement
  • Gross operating margin -€3,469

    down €3,469 (-8.0%), from €43,206 to €39,736

  • Financial charges -€1,207

    down €1,207 (-70.7%), from €1,707 to €500

  • Financial income +€911

    up €911 (+317%), from €287 to €1,199

    of which Non-recurring financial income: +€1,199

  • Taxes -€578

    down €578 (-62.0%), from €932 to €354

Change in the result, 2023 to 2024

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2023 -€26,815
Gross operating margin -€3,469
Staff costs -€412
Depreciation +€146
Other operating charges -€82
Financial income +€911
Financial charges +€1,207
Taxes +€578
Result 2024 -€27,936
raises the resultlowers the result

Derived cash bridge

cash 2023 to 2024

The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€6,057
Investment +€15,000
Financing -€13,426
Cash 2023 €53,691
Net result for the year -€27,936
Depreciation +€20,663
Stocks and contracts -€5,383
Receivables within one year +€37,141
Deferred charges and accrued income +€2,029
Trade debts -€14,626
Tax, wage and social debts -€21,288
Other debts +€3,342
Current investments +€15,000
Debts after one year -€11,268
Current portion of long-term debt -€2,158
Cash 2024 €49,208
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2023 2024 Change %
Total assets 20/58 €276,687 €202,753 -€73,934 -26.7%
Fixed assets 21/28 €26,050 €5,387 -€20,663 -79.3%
Tangible fixed assets 22/27 €24,951 €4,287 -€20,663 -82.8%
Plant, machinery and equipment 23 €931 €32 -€899 -96.5%
Furniture and vehicles 24 €4,164 €1,468 -€2,695 -64.7%
Other tangible fixed assets 26 €19,856 €2,787 -€17,069 -86.0%
Financial fixed assets 28 €1,100 €1,100 = 0.0%
Current assets 29/58 €250,636 €197,366 -€53,271 -21.3%
Stocks and contracts in progress 3 €71,403 €76,785 +€5,383 +7.5%
Stocks 30/36 €71,403 €76,785 +€5,383 +7.5%
Amounts receivable within one year 40/41 €55,957 €18,815 -€37,141 -66.4%
Trade receivables 40 €20,957 €17,782 -€3,175 -15.1%
Other amounts receivable 41 €35,000 €1,033 -€33,967 -97.0%
Current investments 50/53 €60,453 €45,453 -€15,000 -24.8%
Cash at bank and in hand 54/58 €53,691 €49,208 -€4,483 -8.3%
Deferred charges and accrued income 490/1 €9,133 €7,104 -€2,029 -22.2%
Total equity and liabilities 10/49 €276,687 €202,753 -€73,934 -26.7%
Equity 10/15 €126,343 €98,407 -€27,936 -22.1%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €1,859 €1,859 = 0.0%
Non-distributable reserves 130/1 €1,859 €1,859 = 0.0%
Reserves not available under the articles 1311 €1,859 €1,859 = 0.0%
Profit (loss) carried forward 14 €105,892 €77,956 -€27,936 -26.4%
Amounts payable 17/49 €150,344 €104,346 -€45,998 -30.6%
Amounts payable after more than one year 17 €11,268 - -€11,268
Financial debts 170/4 €11,268 - -€11,268
Amounts payable within one year 42/48 €139,075 €104,346 -€34,730 -25.0%
Current portion of amounts payable after more than one year 42 €13,382 €11,224 -€2,158 -16.1%
Trade debts 44 €37,282 €22,656 -€14,626 -39.2%
Suppliers 440/4 €37,282 €22,656 -€14,626 -39.2%
Taxes, remuneration and social security 45 €25,614 €4,326 -€21,288 -83.1%
Taxes 450/3 €19,292 €4,326 -€14,966 -77.6%
Remuneration and social security 454/9 €6,322 - -€6,322
Other amounts payable 47/48 €62,797 €66,139 +€3,342 +5.3%
Remuneration, social security and pensions 62 €46,347 €46,759 +€412 +0.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €20,809 €20,663 -€146 -0.7%
Other operating charges 640/8 €512 €594 +€82 +16.0%
Gross operating margin 9900 €43,206 €39,736 -€3,469 -8.0%
Operating profit (loss) 9901 -€24,464 -€28,281 -€3,817 -15.6%
Financial income 75/76B €287 €1,199 +€911 +317%
Recurring financial income 75 €287 €1,199 +€911 +317%
Non-recurring financial income 76B - €1,199 +€1,199
Financial charges 65/66B €1,707 €500 -€1,207 -70.7%
Recurring financial charges 65 €1,707 €500 -€1,207 -70.7%
Profit (loss) for the period before taxes 9903 -€25,883 -€27,582 -€1,698 -6.6%
Income taxes 67/77 €932 €354 -€578 -62.0%
Profit (loss) for the period 9904 -€26,815 -€27,936 -€1,121 -4.2%
Profit (loss) for the period to be appropriated 9905 -€26,815 -€27,936 -€1,121 -4.2%

Value

latest balance sheet 31-12-2024 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€98,407 to €98,407

Midpoint €98,407 · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €98,407
Indication €98,407

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
€98,407
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€98,407

Capitalised earnings

net result for the year (9904)
2024
-€27,936
excluding non-recurring income and charges
-€29,135
2023
-€26,815
2022
-€18,971
2021
-€75,529
2020
-€38,380
Average result, excluding non-recurring income and charges
-€24,974
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 16 November 2026 via checked.be.